In fact, CD4S and TB1/TB2-specific T cell clones could be the main source of the higher serum levels of IFN-γ observed in patients with COVID-19 and LTBI versus COVID-19 in Rajamanickam et al. This evidence concerns the gene REEP5 and COVID-19.